sinus infection; I got shingles; MAC lungs; did not feel well; nausea/sick to her stomach/wants to throw up; headache; achy all over, aching for two days; low grade temperature; inside of her nose has been sore; Initial case contained only non-serious AEs (not fully processed yet), upon FU PRD/SRD (30Sep2021), event: mycobacterium avium complex infection pertains to MedDRA CTL. FU PRD/SRD (30Sep2021) is considered as significant.  This is a spontaneous report from a contactable consumer (patient). This 71-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Batch/Lot Number: ER8727; Expiration Date: 31Jul2021), dose 2, via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 71-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included ongoing eczema, ongoing psoriasis and arthropathy from an unknown date and unknown if ongoing. The patient previously received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Batch/lot number: EN6200, Expiration date: 30Jun2021), dose 1, via an unspecified route of administration on 01Mar2021 as DOSE 1, SINGLE for COVID-19 immunization and experienced a "delayed reaction". Concomitant medication included chondroitin sulfate, glucosamine hydrochloride (OSTEO BI-FLEX [CHONDROITIN SULFATE;GLUCOSAMINE HYDROCHLORIDE]) taken for arthropathy from an unspecified start date and ongoing; vitamin b complex (B COMPLEX [VITAMIN B COMPLEX]) taken for an unspecified indication from an unspecified start date and ongoing; colecalciferol (D3) taken for an unspecified indication from an unspecified start date and ongoing; vitamin e nos (VITAMIN E [VITAMIN E NOS]) taken for an unspecified indication from an unspecified start date and ongoing; bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]) taken for an unspecified indication, start and stop date were not reported; fish oil, tocopherol (OMEGA 3 [FISH OIL;TOCOPHEROL]) taken for an unspecified indication from an unspecified start date and ongoing; clobetasol propionate (CLOBETASOL PROPIONATE) taken for eczema from an unspecified start date and ongoing; desonide (DESONIDE) taken for eczema from an unspecified start date and ongoing; ketoconazole (KETOCONAZOLE) taken for eczema from an unspecified start date and ongoing; and triamcinolone acetonide (TRIAMCINOLONE ACETONIDE) taken for psoriasis, eczema from an unspecified start date and ongoing. The reporter stated she did not have any side effects until 05Apr2021 (Day 13) after the injection. On 05Apr2021, the patient experienced a headache, aching for two days and a low grade temperature. On 06Apr2021, the patient was sore all over, did not feel well, experienced nausea, sick to her stomach, that has been so bad she wants to throw up but has not thrown up, and the inside of her nose has been sore since Saturday (03Apr2021). The low grade temperature was gone. The patient mentioned having high winds in her area and sometimes this can cause issues with her nose and sinuses. She thought maybe she was getting a sinus infection but she also wants to know if it is possible to have side effects from the vaccine this many days after receiving the second dose. On 17May2021, the patient tested positive for a blood test indicating mycobacterium avium complex (MAC) lung. The patient reported she was asymptomatic on the MAC lung. On 16Jul2021, the patient experienced shingles. The patient underwent lab tests and procedures which included blood test (17May2021): positive for MAC lung (blood test on 17May2021 and the report came out on 27May2021). Clinical outcome of the events nausea/sick to her stomach, did not feel well, aching all over, headache and inside of her nose has been sore was not resolved. Clinical outcome of the events low grade temperature was resolved. Clinical outcome of sinus infection, MAC lung and shingles was unknown.